Atlas Trials

Organon and Co

505 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Organon and Co

RecordFirmDate
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis (NCT07265479)Organon and Co2025-12-29
Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients (NCT05761444)Organon and Co2023-07-26
A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region (NCT05789576)Organon and Co2023-03-13
A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis (NCT05680740)Organon and Co2022-12-27
A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain (NCT05560646)Organon and Co2022-10-25
Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive (NCT05264506)Organon and Co2022-02-17
Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects (NCT05172726)Organon and Co2021-12-02
Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis (NCT05186805)Organon and Co2021-11-15
Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis (NCT05142774)Organon and Co2021-10-28
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102) (NCT05032859)Organon and Co2021-09-23
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (NCT05014568)Organon and Co2021-09-01
A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060) (NCT04626596)Organon and Co2020-11-19
Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis (NCT04042103)Organon and Co2019-07-23
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002) (NCT03983980)Organon and Co2019-06-06
Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439) (NCT03768427)Organon and Co2019-05-27
Next →

Track Organon and Co automatically

Every clearance here is in the API, with alerts when new ones post.